# Modafinil for Atypical Depression

> **NCT00215176** · PHASE2,PHASE3 · COMPLETED · sponsor: **Duke University** · enrollment: 65 (—)

## Conditions studied

- Atypical Depression

## Interventions

- **DRUG:** modafinil

## Key facts

- **NCT ID:** NCT00215176
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 65 (—)
- **Last updated:** 2013-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00215176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00215176, "Modafinil for Atypical Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00215176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*